-

Viz.ai Wins Comparably Awards for Best Place to Work for Second Year

Healthcare AI leader recognized for its outlook and leadership

original Viz.ai Wins Comparably Awards for Best Place to Work for Second Year (Graphic: Business Wire)

Viz.ai Wins Comparably Awards for Best Place to Work for Second Year (Graphic: Business Wire)

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has been named a Best Place to Work by Comparably two years in a row. The Company received two Comparably Best Place to Work Awards for Best Company Outlook and Best Leadership Teams in 2023.

“We are honored that Viz.ai has received these two distinguished awards for our outstanding workplace culture. These awards are a reflection of the hard work of our dedicated team and our steadfast commitment to delivering on our mission to increase access to life-saving treatments,” said Dawn Sprague, vice president of people at Viz.ai. “It is our top priority to foster an environment where everyone can thrive and grow, and we continue to invest in a culture that nurtures each individual’s goals and personal growth.”

Comparably recognizes exceptional companies with the Best Place to Work Awards based on anonymous employee ratings about their workplaces over a 12-month period. The final data set was compiled from over 20 million ratings across 70,000 companies.

In 2022, Viz.ai was recognized for Best Company Culture, Best Company for Diversity, Best Company Outlook and Best Company Career Growth.

To learn about opportunities to join Viz.ai, please visit https://www.viz.ai/careers.

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,400+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Laurie Masonson
laurie.masonson@finnpartners.com

Industry:

Viz.ai, Inc.

Release Versions
English
Hashtags
#ai
#aiinhealthcare
#carecoordination
#partnerships

Contacts

Laurie Masonson
laurie.masonson@finnpartners.com

Social Media Profiles
Viz.ai
Viz.ai
More News From Viz.ai, Inc.

Viz.ai and Salesforce Collaborate to Transform Pharma Engagement With Real-Time Clinical Intelligence for Agentforce

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new real-time clinical intelligence service for Salesforce’s Agentforce Life Sciences. These services will power new and existing agentic solutions for life sciences customers, including a data integration that will bring Viz.ai’s real-time data, triggers, and clinical intelligence layer from across a network of nearly 2,000 hospitals covering 230...

Viz.ai Closes 2025 with Record Scale and Patient Impact, Achieving Profitability in Its Healthcare Business while Accelerating Life Sciences Growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a milestone year marked by record growth in its provider footprint, profitability across its healthcare business, the launch of Viz Oncology and Viz Assist, and the doubling of its life sciences business over the past 18 months. Viz.ai is now adopted in nearly 2,000 hospitals across the United States, including the majority of the 50 largest health systems, suppo...

Viz.ai and NCCN Collaborate to Integrate NCCN Guidelines into Clinical Workflows for Oncologists

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an agreement with the National Comprehensive Cancer Network® (NCCN®). This collaboration integrates NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast, Prostate, and Bladder Cancer into the Viz Oncology Platform making this important information readily available to clinicians when they’re making critical decisions about patient care. Thr...
Back to Newsroom